Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
$65.30
-2.4%
$55.40
$33.86
$68.09
$1.46B1.45849,140 shs102,460 shs
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$33.41
-3.6%
$33.28
$29.31
$61.38
$3.99B0.591.52 million shs186,652 shs
FedEx Corporation stock logo
FDX
FedEx
$239.44
-0.7%
$222.83
$194.30
$313.84
$57.42B1.351.85 million shs482,590 shs
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
$9.15
-0.6%
$7.53
$4.62
$13.47
$572.66M0.291.30 million shs277,999 shs
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
$99.78
-0.4%
$94.26
$77.85
$125.81
$22.00B1.491.53 million shs162,969 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
0.00%+11.91%+22.26%+84.73%+71.93%
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
0.00%+2.23%+4.95%-5.81%-38.93%
FedEx Corporation stock logo
FDX
FedEx
0.00%+5.01%+9.51%+17.43%-18.07%
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
0.00%+0.49%+34.23%+38.06%-14.70%
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
0.00%+4.49%+6.51%+22.97%-12.52%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
4.3156 of 5 stars
2.02.02.52.52.03.32.5
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
3.9355 of 5 stars
4.52.00.04.60.00.80.0
FedEx Corporation stock logo
FDX
FedEx
4.7921 of 5 stars
3.35.02.51.33.41.71.9
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
3.2267 of 5 stars
2.02.00.04.12.31.70.6
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
4.5727 of 5 stars
1.81.05.03.24.12.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
2.00
Hold$53.86-17.52% Downside
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
2.93
Moderate Buy$70.92112.31% Upside
FedEx Corporation stock logo
FDX
FedEx
2.60
Moderate Buy$282.4617.97% Upside
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
2.00
Hold$8.93-2.31% Downside
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
1.67
Reduce$94.91-4.88% Downside

Current Analyst Ratings Breakdown

Latest FDX, CYTK, TROW, SAGE, and CBRL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/3/2025
FedEx Corporation stock logo
FDX
FedEx
BNP Paribas Exane
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Outperform$270.00
7/2/2025
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$95.00 ➝ $104.00
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$315.00
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$275.00
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$270.00 ➝ $245.00
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$275.00 ➝ $260.00
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$267.00 ➝ $259.00
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$260.00 ➝ $290.00
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetPositive ➝ Positive$290.00 ➝ $295.00
6/25/2025
FedEx Corporation stock logo
FDX
FedEx
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$311.00 ➝ $297.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
$3.47B0.42$9.21 per share7.09$19.82 per share3.29
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$19.22M207.59N/AN/A($1.15) per share-29.05
FedEx Corporation stock logo
FDX
FedEx
$87.93B0.65$36.01 per share6.65$117.17 per share2.04
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
$41.24M13.89N/AN/A$7.60 per share1.20
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
$7.09B3.10$11.85 per share8.42$47.29 per share2.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
$40.93M$2.5825.3821.066.231.65%16.83%3.53%9/18/2025 (Estimated)
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
-$589.53M-$5.29N/AN/AN/A-3,201.47%N/A-43.75%8/6/2025 (Estimated)
FedEx Corporation stock logo
FDX
FedEx
$4.09B$16.8814.2011.061.264.65%16.34%5.14%9/18/2025 (Estimated)
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
-$400.67M-$5.80N/AN/AN/A-747.63%-68.99%-60.67%7/30/2025 (Estimated)
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
$2.10B$8.8211.3210.373.2128.38%20.17%15.48%8/1/2025 (Estimated)

Latest FDX, CYTK, TROW, SAGE, and CBRL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q2 2025
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
-$0.96N/AN/AN/A$16.69 millionN/A
7/25/2025Q2 2025
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
$1.99N/AN/AN/A$1.72 billionN/A
6/24/2025Q4 2025
FedEx Corporation stock logo
FDX
FedEx
$5.98$6.07+$0.09$6.88$21.86 billion$22.20 billion
6/5/2025Q3 2025
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
$0.17$0.58+$0.41$0.56$824.65 million$821.10 million
5/6/2025Q1 2025
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
-$1.41-$1.36+$0.05-$1.36$2.77 million$1.60 million
5/2/2025Q1 2025
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
$2.13$2.23+$0.10$2.15$1.80 billion$1.76 billion
4/29/2025Q1 2025
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
-$0.99-$1.01-$0.02-$1.01$14.12 million$14.06 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
$1.001.53%N/A38.76%N/A
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
N/AN/AN/AN/AN/A
FedEx Corporation stock logo
FDX
FedEx
$5.802.42%N/A34.36%1 Years
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
N/AN/AN/AN/AN/A
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
$5.085.09%N/A57.60%39 Years

Latest FDX, CYTK, TROW, SAGE, and CBRL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2025
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
quarterly$0.251.72%7/18/20257/18/20258/13/2025
6/9/2025
FedEx Corporation stock logo
FDX
FedEx
quarterly$1.452.61%6/23/20256/23/20257/8/2025
5/9/2025
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
quarterly$1.275.47%6/13/20256/13/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
1.04
0.65
0.26
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
N/A
5.99
5.99
FedEx Corporation stock logo
FDX
FedEx
0.68
1.19
1.15
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
N/A
9.13
9.13
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
N/A
3.89
3.89

Institutional Ownership

CompanyInstitutional Ownership
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
96.01%
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
N/A
FedEx Corporation stock logo
FDX
FedEx
84.47%
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
99.22%
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
73.39%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cracker Barrel Old Country Store, Inc. stock logo
CBRL
Cracker Barrel Old Country Store
77,60022.27 million21.96 millionOptionable
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
250119.43 million115.37 millionOptionable
FedEx Corporation stock logo
FDX
FedEx
430,000239.60 million218.35 millionOptionable
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
69062.62 million59.18 millionOptionable
T. Rowe Price Group, Inc. stock logo
TROW
T. Rowe Price Group
8,158220.32 million216.79 millionOptionable

Recent News About These Companies

Where T. Rowe Price Group Stands With Analysts

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cracker Barrel Old Country Store stock logo

Cracker Barrel Old Country Store NASDAQ:CBRL

$65.30 -1.58 (-2.36%)
As of 10:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cracker Barrel Old Country Store, Inc. develops and operates the Cracker Barrel Old Country Store concept in the United States. Its Cracker Barrel stores consist of restaurants with a gift shop. The company's restaurants serve breakfast, lunch, and dinner daily, as well as dine-in, pick-up, and delivery services. Its gift shop offers various decorative and functional items, such as rocking chairs, seasonal gifts, apparel, toys, food, cookware, and various other gift items, as well as various candies, preserves, and other food items. The company was incorporated in 1969 and is headquartered in Lebanon, Tennessee.

Cytokinetics stock logo

Cytokinetics NASDAQ:CYTK

$33.40 -1.26 (-3.62%)
As of 10:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. The company also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase I clinical trial; and aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated has a strategic alliance with Ji Xing Pharmaceuticals Limited. The company was incorporated in 1997 and is headquartered in South San Francisco, California.

FedEx stock logo

FedEx NYSE:FDX

$239.44 -1.79 (-0.74%)
As of 10:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FedEx Corporation provides transportation, e-commerce, and business services in the United States and internationally. It operates through FedEx Express, FedEx Ground, FedEx Freight, and FedEx Services segments. The FedEx Express segment offers express transportation, small-package ground delivery, and freight transportation services; and time-critical transportation services. The FedEx Ground segment provides small-package ground delivery services. The FedEx Freight segment offers less-than-truckload freight transportation services. The FedEx Services segment provides sales, marketing, information technology, communications, customer service, technical support, billing and collection, and back-office support services. In addition, the company offers supply chain management solutions; and air and ocean cargo transportation, specialty transportation, customs brokerage, and trade management tools and data. The company was founded in 1971 and is headquartered in Memphis, Tennessee.

Sage Therapeutics stock logo

Sage Therapeutics NASDAQ:SAGE

$9.14 -0.06 (-0.60%)
As of 10:56 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO, a CIV injection for the treatment of postpartum depression (PPD) in adults; and ZURZUVAE, a neuroactive steroid, a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors, for the treatment of postpartum depression. Its product pipeline also comprises SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has completed Phase I clinical trial for epilepsy and Parkinson's diseases; and SAGE-718, an oxysterol-based positive allosteric modulator of the NMDA receptor, which is in Phase II clinical trial for the treatment of depression, Huntington's disease, Parkinson's diseases, Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, and neuropathic pain. The company has a strategic collaboration with Shionogi & Co., Ltd. for the development and commercialization of zuranolone in Japan, Taiwan, and South Korea; and a collaboration and license agreement with Biogen MA Inc. to jointly develop and commercialize SAGE-217 and SAGE-324 products. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

T. Rowe Price Group stock logo

T. Rowe Price Group NASDAQ:TROW

$99.78 -0.37 (-0.37%)
As of 10:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity and fixed income markets across the globe. It employs fundamental and quantitative analysis with a bottom-up approach. The firm utilizes in-house and external research to make its investments. It employs socially responsible investing with a focus on environmental, social, and governance issues. It makes investment in late-stage venture capital transactions and usually invests between $3 million and $5 million. The firm was previously known as T. Rowe Group, Inc. and T. Rowe Price Associates, Inc. T. Rowe Price Group, Inc. was founded in 1937 and is based in Baltimore, Maryland, with additional offices in Colorado Springs, Colorado; Owings Mills, Maryland; San Francisco, California; New York, New York; Philadelphia, Pennsylvania; Tampa, Florida; Toronto, Ontario; Hellerup, Denmark; Amsterdam, The Netherlands; Luxembourg, Grand Duchy of Luxembourg; Zurich, Switzerland; Dubai, United Arab Emirates; London, United Kingdom; Sydney, New South Wales; Hong Kong; Tokyo, Japan; Singapore; Frankfurt, Shanghai, China; Germany, Madrid, Spain, Milan, Italy, Stockholm, Sweden, Melbourne, Australia, Amsterdam, Netherlands and Washington, DC.